| Hang Seng Index | 25.380 HKD | -0.180 | -0.704% | 277.72M | 7.05B | 25.402 (-0.085%) HKD as at 2025/08/05 | | |
| Hang Seng China Enterprises | 91.160 HKD | -0.760 | -0.827% | 70.05M | 6.39B | 91.618 (-0.499%) HKD as at 2025/08/05 | | |
| Hang Seng TECH Index | 5.360 HKD | -0.085 | -1.561% | 725.06M | 3.90B | 5.425 (-1.191%) HKD as at 2025/08/05 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.350 HKD | -0.150 | -2.727% | 152.40M | 819.70M | 5.495 (-2.644%) HKD as at 2025/08/05 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.608 HKD | +0.044 | +2.813% | 262.27M | 418.59M | 1.567 (+2.590%) HKD as at 2025/08/05 | | |
| Hang Seng TECH Index | 11.520 HKD | -0.140 | -1.201% | 19.30M | 222.78M | 11.551 (-0.272%) HKD as at 2025/08/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.605 HKD | -0.090 | -1.580% | 30.60M | 172.00M | 5.619 (-0.253%) HKD as at 2025/08/05 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.056 HKD | +0.032 | +1.581% | 71.56M | 146.74M | 2.054 (+0.117%) HKD as at 2025/08/05 | | |
| Hang Seng China Enterprises | 10.570 HKD | -0.040 | -0.377% | 13.50M | 142.63M | 10.502 (+0.644%) HKD as at 2025/08/04 | | |
| Hang Seng TECH Index | 5.445 HKD | -0.080 | -1.448% | 17.73M | 96.96M | 5.508 (-1.146%) HKD as at 2025/08/05 | | |
| London Gold Fixing Price | 2,460.000 HKD | +5.000 | +0.204% | 33.18K | 81.39M | N/A | | |
| Hang Seng Hong Kong-Listed Biotech Index | 16.360 HKD | -0.280 | -1.683% | 4.19M | 68.56M | 17.004 (-3.788%) HKD as at 2025/08/05 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.860 HKD | +0.250 | +1.420% | 1.81M | 32.43M | 17.206 (+3.803%) HKD as at 2025/08/04 | | |
| CSI 300 | 46.400 HKD | 0.000 | 0.000% | 511.17K | 23.74M | 46.365 (+0.075%) HKD as at 2025/08/05 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.800 HKD | -0.002 | -0.053% | 5.75M | 21.79M | 3.876 (-1.948%) HKD as at 2025/08/04 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 9.420 HKD | +0.535 | +6.021% | 2.06M | 19.33M | 8.717 (+8.071%) HKD as at 2025/08/05 | | |
| Hang Seng High Dividend Yield | 30.280 HKD | -0.040 | -0.132% | 520.30K | 15.77M | 29.520 (+2.576%) HKD as at 2025/08/04 | | |
| FTSE US Treasury 20+ Years Index | 68.700 HKD | -0.140 | -0.203% | 164.12K | 11.28M | 69.045 (-0.500%) HKD as at 2025/08/04 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.470 HKD | +0.250 | +1.758% | 743.10K | 10.75M | 14.112 (+2.538%) HKD as at 2025/08/05 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 49.920 HKD | -2.220 | -4.258% | 209.99K | 10.46M | 52.783 (-5.423%) HKD as at 2025/08/05 | | |
| FTSE China A50 | 13.830 HKD | -0.060 | -0.432% | 645.93K | 8.95M | 13.821 (+0.063%) HKD as at 2025/08/05 | | |
| London Gold Fixing Price | 80.600 HKD | +0.140 | +0.174% | 90.11K | 7.25M | 79.745 (+1.072%) HKD as at 2025/08/05 | | |
| FTSE China A50 | 14.850 HKD | -0.050 | -0.336% | 453.28K | 6.74M | 14.709 (+0.962%) HKD as at 2025/08/04 | | |
| CME Ether Futures | 18.550 HKD | +1.060 | +6.061% | 360.30K | 6.66M | 17.388 (+6.685%) HKD as at 2025/08/04 | | |
| Solactive China Healthcare Disruption Index | 3.736 HKD | -0.004 | -0.107% | 1.75M | 6.54M | 3.867 (-3.375%) HKD as at 2025/08/05 | | |
| Hang Seng Index | 23.200 CNY | -0.160 | -0.685% | 274.00K | 6.36M | 23.272 (-0.310%) CNY as at 2025/08/05 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.466 HKD | -0.024 | -0.688% | 1.73M | 5.91M | 3.452 (+0.411%) HKD as at 2025/08/05 | | |
| CME Bitcoin Futures | 39.520 HKD | +0.680 | +1.751% | 141.95K | 5.62M | 38.853 (+1.718%) HKD as at 2025/08/04 | | |
| MSCI India Net Total Return (USD) Index | 6.795 HKD | +0.005 | +0.074% | 819.10K | 5.57M | 6.923 (-1.847%) HKD as at 2025/08/04 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.620 HKD | +0.030 | +0.836% | 1.27M | 4.60M | 3.616 (+0.102%) HKD as at 2025/08/05 | | |